We're using a pullback in one of our drug stocks to buy more shares



While mindful of a liability risk, we continue to believe this company’s exposure will be minimal, if anything. 



Source link


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *